CSPC Pharmaceutical Group Limited (CHJTF)
USD 0.65
(0.0%)
USD 0.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 630.45 Million | 1.18 Billion | 751.75 Million | 989.75 Million | 563.75 Million | 574.17 Million |
| Net Income | 830.91 Million | 906.76 Million | 866.24 Million | 747.74 Million | 540.5 Million | 466.83 Million |
| Depreciation & Amortization | 157.62 Million | 155.67 Million | 133.48 Million | 116.96 Million | 100.64 Million | 92.91 Million |
| Deferred income taxes | - | -489.23 Million | -633.95 Million | -113.54 Million | - | - |
| Stock-based compensation | 235.09 Million | 160.72 Million | 17.73 Million | 9.12 Million | 965.25 Thousand | - |
| Change in working capital | -428.92 Million | 118.8 Million | -214.49 Million | 243.49 Million | -70.55 Million | 26.08 Million |
| Other non-cash items | 816.79 Million | 328.17 Million | 582.72 Million | -14.01 Million | 336.01 Million | 285.11 Million |
| Investing Cash Flow | 118.31 Million | -1.04 Billion | -135.72 Million | -335.29 Million | -368.44 Million | -546.96 Million |
| Investments in PPE | -267.81 Million | -405.3 Million | -271.75 Million | -227.79 Million | -308.9 Million | -322.19 Million |
| Acquisitions | 62.68 Million | -42.49 Million | 36.56 Million | -39.64 Million | -68.96 Million | -13.89 Million |
| Investment purchases | -647.63 Million | -1.11 Billion | -835.14 Million | -666.35 Million | -385.41 Million | -596.07 Million |
| Sales/Maturities of investments | 954.84 Million | 508.97 Million | 932.61 Million | 601.12 Million | 396.71 Million | 385.2 Million |
| Other Investing Activities | 16.23 Million | 6.22 Million | 1.99 Million | -2.62 Million | -1.88 Million | - |
| Financing Cash Flow | -404.65 Million | -284.56 Million | -339.38 Million | -212.89 Million | -227.15 Million | -23.33 Million |
| Debt repayment | -3.93 Million | -1.48 Million | -15.29 Million | -24.49 Million | -6.92 Million | -117.26 Million |
| Dividends payments | -2.72 Billion | -312.15 Million | -261.29 Million | -221.39 Million | -140.48 Million | -119.6 Million |
| Common Stock Repurchased | -64.92 Million | -2.11 Million | -40.72 Million | -0.06 | -14.65 Million | -12.65 Million |
| Common Stock Issuance | - | -20.64 Million | -20.13 Million | -14.87 Million | 166.25 Million | - |
| Other Financing Activities | 71.43 Million | 51.84 Million | -1.93 Million | 47.86 Million | -221.93 Million | 226.19 Million |
| Accounts receivables | -465.78 Million | -67.24 Million | -296.65 Million | -6.59 Million | -141.19 Million | -87.89 Million |
| Accounts payables | 117.65 Million | 56.45 Million | 42.77 Million | 48.94 Million | -74.49 Million | 69.87 Million |
| Inventory | -82.58 Million | -6.36 Million | -95.36 Million | 87.16 Million | 74.11 Million | -92.92 Million |
| Other working capital | 1.78 Million | 135.95 Million | 134.75 Million | 113.98 Million | 71 Million | 137.02 Million |
| Cash at beginning of period | 1.48 Billion | 1.45 Billion | 1.11 Billion | 617.96 Million | 629.69 Million | 670.5 Million |
| Cash at end of period | 1.69 Billion | 1.48 Billion | 1.45 Billion | 1.11 Billion | 617.96 Million | 629.69 Million |
| Capital Expenditure | -267.81 Million | -405.3 Million | -271.75 Million | -227.79 Million | -308.9 Million | -322.19 Million |
| Effect of forex changes on cash | 4.89 Million | 14.13 Million | -2.44 Million | 2.1 Million | -1.03 | - |
| Net cash flow / Change in cash | 213.63 Million | 23.82 Million | 340.59 Million | 497.67 Million | -11.73 Million | -40.8 Million |
| Free Cash Flow | 362.63 Million | 775.61 Million | 479.99 Million | 761.95 Million | 254.84 Million | 251.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 193.67 Million | 223.37 Million | 830.91 Million | 194.24 Million | 209.23 Million | 211.99 Million |
| Depreciation & Amortization | - | - | 157.62 Million | 80.76 Million | - | 76.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 7.28 Million | 9.04 Million | 235.09 Million | 9.26 Million | 8.18 Million | 8.13 Million |
| Change in working capital | - | - | -428.92 Million | - | - | - |
| Other non-cash items | -200.95 Million | -232.41 Million | 816.79 Million | -203.51 Million | -217.42 Million | -220.12 Million |
| Investing Cash Flow | - | - | 118.31 Million | -42.84 Million | - | 157.94 Million |
| Investments in PPE | - | - | -267.81 Million | -113.55 Million | - | -147.75 Million |
| Acquisitions | - | - | 62.68 Million | -2.24 Million | - | 63.3 Million |
| Investment purchases | - | - | -647.63 Million | -56.65 Million | - | -574.45 Million |
| Sales/Maturities of investments | - | - | 954.84 Million | 82.94 Million | - | 847.53 Million |
| Other Investing Activities | - | - | 16.23 Million | 46.66 Million | - | -30.67 Million |
| Financing Cash Flow | - | - | -404.65 Million | -190.77 Million | - | -204.11 Million |
| Debt repayment | - | - | -3.93 Million | -3.11 Million | - | -4.99 Million |
| Dividends payments | - | - | -385.69 Million | -202.78 Million | - | -173.66 Million |
| Common Stock Repurchased | - | - | -64.92 Million | -34.46 Million | - | -28.9 Million |
| Common Stock Issuance | - | - | - | -8.57 Million | - | 8.53 Million |
| Other Financing Activities | - | - | 71.43 Million | 73.6 Million | - | -3.75 Million |
| Accounts receivables | - | - | -465.78 Million | - | - | - |
| Accounts payables | - | - | 117.65 Million | - | - | - |
| Inventory | - | - | -82.58 Million | - | - | - |
| Other working capital | - | - | 1.78 Million | - | - | - |
| Cash at beginning of period | - | - | 1.48 Billion | 1.44 Billion | - | 1.48 Billion |
| Cash at end of period | - | - | 1.69 Billion | 1.48 Billion | - | 1.44 Billion |
| Capital Expenditure | - | - | -267.81 Million | -113.55 Million | - | -147.75 Million |
| Effect of forex changes on cash | - | - | 4.89 Million | - | - | -0.10 |
| Net cash flow / Change in cash | - | - | 213.63 Million | 41.96 Million | - | -39.76 Million |
| Free Cash Flow | - | - | 362.63 Million | 293.87 Million | - | 60.44 Million |
TROW
605286
6023
ENTA
6626
RGLD